Crinetics Pharmaceuticals Total Non-Operating Income/Expense 2017-2024 | CRNX

Crinetics Pharmaceuticals total non-operating income/expense for the twelve months ending September 30, 2024 was $0.034B, a 269.25% increase year-over-year.

  • Crinetics Pharmaceuticals annual total non-operating income/expense for 2023 was $0.013B, a 166.93% increase from 2022.
  • Crinetics Pharmaceuticals annual total non-operating income/expense for 2022 was $0.005B, a 8054.1% increase from 2021.
  • Crinetics Pharmaceuticals annual total non-operating income/expense for 2021 was $0B, a 94.65% decline from 2020.

Crinetics Pharmaceuticals Total Non-Operating Income/Expense 2017-2024 | CRNX

  • Crinetics Pharmaceuticals annual total non-operating income/expense for 2023 was $0.013B, a 166.93% increase from 2022.
  • Crinetics Pharmaceuticals annual total non-operating income/expense for 2022 was $0.005B, a 8054.1% increase from 2021.
  • Crinetics Pharmaceuticals annual total non-operating income/expense for 2021 was $0B, a 94.65% decline from 2020.